body.layout-boxed.body--hand-drawn .handborder--left,body.layout-boxed.body--hand-drawn .handborder--right{--wpr-bg-78c2abdd-ae7c-4d8f-a339-9f0edc9cf05c: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/line.webp');}body.layout-boxed.body--hand-drawn .handborder--top,body.layout-boxed.body--hand-drawn .handborder--bottom{--wpr-bg-8474f4ce-11d4-43e8-b40a-54f2c3f6afe6: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/line-h.webp');}blockquote:before,.wp-block-quote.is-large:before,.wp-block-quote.is-style-large:before{--wpr-bg-21efbd80-f5c7-49a3-b303-828c457eb980: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/quote.webp');}.style--blockquote--icon-2 blockquote:before,.style--blockquote--icon-2 .wp-block-quote.is-large:before,.style--blockquote--icon-2 .wp-block-quote.is-style-large:before{--wpr-bg-1c38f8f2-7448-4bd1-a310-6bd4ce6a42cc: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/quote2.webp');}.style--blockquote--icon-3 blockquote:before,.style--blockquote--icon-3 .wp-block-quote.is-large:before,.style--blockquote--icon-3 .wp-block-quote.is-style-large:before{--wpr-bg-1007de31-05ae-47ac-adc0-3eccc9f1e731: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/quote3.webp');}.style--blockquote--icon-4 blockquote:before,.style--blockquote--icon-4 .wp-block-quote.is-large:before,.style--blockquote--icon-4 .wp-block-quote.is-style-large:before{--wpr-bg-3b1a2c12-9ddf-4f89-ae2a-14fbeead59d2: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/quote4.webp');}.no-webp blockquote:before,.no-webp .wp-block-quote.is-large:before,.no-webp .wp-block-quote.is-style-large:before{--wpr-bg-8486c949-589a-4d83-8167-ce0725dc7a2b: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/quote.png');}.no-webp .style--blockquote--icon-2 blockquote:before,.no-webp .style--blockquote--icon-2 .wp-block-quote.is-large:before,.no-webp .style--blockquote--icon-2 .wp-block-quote.is-style-large:before{--wpr-bg-01b03720-f27b-472a-9e97-4810a9ea99fa: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/quote2.png');}.no-webp .style--blockquote--icon-3 blockquote:before,.no-webp .style--blockquote--icon-3 .wp-block-quote.is-large:before,.no-webp .style--blockquote--icon-3 .wp-block-quote.is-style-large:before{--wpr-bg-aebc8975-8b75-492a-bd42-8c62fa97e9e1: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/quote3.png');}.no-webp .style--blockquote--icon-4 blockquote:before,.no-webp .style--blockquote--icon-4 .wp-block-quote.is-large:before,.no-webp .style--blockquote--icon-4 .wp-block-quote.is-style-large:before{--wpr-bg-b24460f9-9034-438b-8952-9958f04f8e7e: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/quote4.png');}.fox-library-modal-btn:before{--wpr-bg-1b6c3a8a-5bb3-4bd5-9603-4186f7569572: url('https://b6620556.delivery.rocketcdn.me/wp-content/themes/fox/images/foxhead.png');}.rll-youtube-player .play{--wpr-bg-2b723028-9abc-4da6-b422-277009581702: url('https://b6620556.delivery.rocketcdn.me/wp-content/plugins/wp-rocket/assets/img/youtube.png');}

fármaco antiviral

Name: Aplican antiviral Nasalferón para contener COVID-19 en Ciego de Ávila
Uploaded: 2020-09-17T21:44:16-04:00
Channel: Pedro Ramos
Description: Las autoridades de salud de la provincia de Ciego de Ávila aseguraron que, disponen de 34 mil dosis del antiviral Nasalferón para contener el coronavirus.

Actualidad Noticias de Hoy

Aplican antiviral Nasalferón para “contener propagación de la COVID-19” en Ciego de Ávila (+VIDEO)

Sep 17, 2020

Por Pedro Ramos

Las autoridades de salud de la provincia de Ciego de Ávila aseguraron que, disponen de 34 mil dosis del antiviral Nasalferón con el cual

Internacionales

Agencia Europea del Medicamento da luz verde al remdesivir como primer fármaco para tratar la COVID-19

Jun 25, 2020

Por Amalia Leonor Gómez

El remdesivir ha obtenido la aprobación de la Agencia Europea del Medicamento para la comercialización para tratar a pacientes con COVID-19 que se encuentren

Ir aArriba